LONGCOVID: Cognitive-behavioral Therapy for Mental Disorder in COVID-19 Survivors
Study Details
Study Description
Brief Summary
The consequences of the Intensive Care Unit and the Covid-19 disease are still uncertain. However, many studies are bringing out often psychological and dramatic consequences for many COVID-survivor patients.
Among the ex-covid patients discharged from our Intensive Care Unit and with at least one covid-related psychological consequence, we want to evaluate the effectiveness for long-term consequences of COVID-19 of mindfulness-based stress reduction (MBSR) and cognitive behavioral therapy (CBT) or usual care.
Condition or Disease | Intervention/Treatment | Phase |
---|---|---|
|
N/A |
Detailed Description
Randomized controlled clinical study. All patients who survived COVID-19 and discharged from the intensive care unit of the Lecco hospital will be enrolled if present: chronic pain, anxiety, depression and/or insomnia in pharmacological therapy A group of patients will be observed during 12 months and evaluated with rating scales for chronic pain, anxiety, depression and insomnia.
The second (experimental) group will receive psychotherapy (mindfulness-based stress reduction and cognitive behavioral therapy) in addition to the pharmacological therapy
Study Design
Arms and Interventions
Arm | Intervention/Treatment |
---|---|
No Intervention: Group 1 usual care for anxiety, depression, chronic pain and insomnia |
|
Experimental: Group 2 mindfulness-based stress reduction (MBSR) and cognitive behavioral therapy (CBT) for anxiety, depression, chronic pain and insomnia |
Behavioral: mindfulness-based stress reduction (MBSR) and cognitive behavioral therapy (CBT)
Patients with long-term consequences of COVID-19 (Chronic pain, anxiety, depression or insomnia) enrolled and randomly assigned to receive MBSR and CBT CBT (n = 63), or usual care (n = 62).CBT (training to change -related thoughts and behaviors) and MBSR (training in mindfulness meditation and yoga) were delivered in 12 months with 2-hour groups each 2 months. Usual care included anything care participants received such as drug therapy.
|
Outcome Measures
Primary Outcome Measures
- Chronic pain [6 months and 1 year]
pain that persists or recurs for longer than 3 months, and it exerts an enormous personal and economic burden, affecting more than 30% of people worldwide
- Anxiety [6 months and 1 year]
an emotion characterized by feelings of tension, worried thoughts, and physical changes like increased blood pressure
- Depression [6 months and 1 year]
a depressed mood or loss of pleasure or interest in activities for long periods of time
- Insomnia [6 months and 1 year]
a common sleep disorder that can make it hard to fall asleep, hard to stay asleep, or cause you to wake up too early and not be able to get back to sleep
Eligibility Criteria
Criteria
Inclusion Criteria:
-
Intensive care survivors
-
Surviving COVID-19 patients
-
Patients with Chronic Pain Anxiety Depression and/or Insomnia in drug therapy
Exclusion Criteria:
-
Patients with Chronic Pain Anxiety Depression and/or Insomnia NOT in drug therapy
-
Patients not hospitalized in intensive care for COVID-19
Contacts and Locations
Locations
Site | City | State | Country | Postal Code | |
---|---|---|---|---|---|
1 | ASST Lecco | Lecco | Italy | 23814 |
Sponsors and Collaborators
- Azienda Socio Sanitaria Territoriale di Lecco
Investigators
- Principal Investigator: Vincenzo Damico, Azienda Socio Sanitaria Territoriale di Lecco
Study Documents (Full-Text)
None provided.More Information
Publications
None provided.- ASST LECCO, DEP. ICU